AstraZeneca deal to supply EU with 300 million COVID-19 vaccine doses - CGTN
AstraZeneca aims to go carbon free by 2025—and it'll spend $1B to do it | FiercePharma
Impact of a five-dimensional framework on R&D productivity at AstraZeneca | Nature Reviews Drug Discovery
Why AstraZeneca and others racing to make a COVID-19 vaccine should be more open about the process
AstraZeneca Covid-19 vaccine study is put on hold
A leading coronavirus vaccine trial is on hold: scientists react
AstraZeneca partners its way to a genomic bounty | Science | AAAS
AstraZeneca Faces Difficult Questions About Its Vaccine After Admitting Mistake - The New York Times
AstraZeneca accelerates drug discovery thanks to PELE technology | BSC-CNS
COVID-19: Difficult trade-offs in AstraZeneca vaccine development | Science| In-depth reporting on science and technology | DW | 28.10.2020
Egypt - AstraZeneca
The COVID vaccine challenges that lie ahead
Investments in health systems
Oxford and AstraZeneca to resume Covid vaccine trial, Health News, ET HealthWorld
News in brief | Nature Reviews Drug Discovery
AstraZeneca México - Videos | Facebook
Oxford Covid-19 vaccine trial put on hold after participant falls ill
PDF) Lessons learned from the fate of AstraZeneca's drug pipeline: A five-dimensional framework
Israel - AstraZeneca
AstraZeneca accelerates drug discovery thanks to PELE technology | BSC-CNS
COVID-19: Difficult trade-offs in AstraZeneca vaccine development | Science| In-depth reporting on science and technology | DW | 28.10.2020
Scientists relieved as coronavirus vaccine trial restarts — but question lack of transparency
EUR068: Enforcement (No. 2006/857/EC, Case COMP/A.37.507/F3 — AstraZeneca), Decision, 2005
